N-Nitroso dabigatran Impurity
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds .Dabigatran is used to treat deep vein thrombosis (DVT; a blood clot, usually in the leg) and pulmonary embolism (PE; a blood clot in the lung) in adults and children 3 months of age and older who have been treated with an injectable anticoagulant ('blood thinner').N-Nitroso Dabigatran Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Dabigatran Impurity 1 CAS NO: 2892260-29-4 also known as N-Nitroso Dabigatran Etexilate or N-Nitroso dabigatran Impurity & it is chemically represented as ethyl 3-(2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl)phenyl)(nitroso)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate. Synchemia is the leading manufacturing and exporter of N-Nitroso Dabigatran Impurity 1 .We supply N-Nitroso Dabigatran Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142131 |
| CAS No | NA |
| Mol.F. | C15H13N3O7 |
| Mol.Wt. | 347.28 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142132 |
| CAS No | NA |
| Mol.F. | C13H11N3O7S |
| Mol.Wt. | 353.31 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142133 |
| CAS No | NA |
| Mol.F. | C31H32ClFN8O3 |
| Mol.Wt. | 619.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142134 |
| CAS No | NA |
| Mol.F. | C29H33ClN8O2 |
| Mol.Wt. | 561.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142135 |
| CAS No | NA |
| Mol.F. | C30H40N8O4 |
| Mol.Wt. | 576.7 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142136 |
| CAS No | NA |
| Mol.F. | C24H36N8O4 |
| Mol.Wt. | 500.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142137 |
| CAS No | NA |
| Mol.F. | C19H28N8O2 |
| Mol.Wt. | 400.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142138 |
| CAS No | NA |
| Mol.F. | C6H9N5O2 |
| Mol.Wt. | 183.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142139 |
| CAS No | NA |
| Mol.F. | C26H34N8O2 |
| Mol.Wt. | 490.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142140 |
| CAS No | NA |
| Mol.F. | C19H28N8O2 |
| Mol.Wt. | 400.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142141 |
| CAS No | NA |
| Mol.F. | C6H10N4O |
| Mol.Wt. | 154.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142142 |
| CAS No | 58246-54-1 |
| Mol.F. | C5H10N2O2 |
| Mol.Wt. | 130.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142143 |
| CAS No | NA |
| Mol.F. | C18H25N9O3 |
| Mol.Wt. | 415.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142144 |
| CAS No | NA |
| Mol.F. | C18H24N10O4 |
| Mol.Wt. | 444.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142145 |
| CAS No | NA |
| Mol.F. | C20H22ClN7O |
| Mol.Wt. | 411.9 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142146 |
| CAS No | NA |
| Mol.F. | C28H30ClN9O3 |
| Mol.Wt. | 576.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |